Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Medical College of Wisconsin

Medical College of Wisconsin in Milwaukee, Wisconsin, United States is listed as a site for 1,371 registered clinical trials, 511 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,371
Ongoing 511

This page covers the site record Medical College of Wisconsin in Milwaukee, Wisconsin, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Medical College of Wisconsin, also sponsors trials.

Get the Medical College of Wisconsin report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,371 trials counted.

  • Phase 1 98 trials
  • Phase 1/2 75 trials
  • Phase 2 336 trials
  • Phase 2/3 54 trials
  • Phase 3 393 trials
  • Phase 4 42 trials
  • Not applicable 205 trials
  • Observational 154 trials
  • Expanded access 14 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 515 trials
  • Completed 649 trials
  • Terminated 161 trials
  • Other 46 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 89

1994: 10 trials (Phase 3 9, Phase 1/2 1) 1995: 4 trials (Phase 3 2, Phase 1/2 1, Phase 1 1) 1996: 3 trials (Phase 3 3) 1997: 13 trials (Phase 3 3, Phase 2 8, Phase 1/2 2) 1998: 21 trials (Observational 1, Phase 3 10, Phase 2 9, Phase 1 1) 1999: 15 trials (Not applicable 1, Phase 4 1, Phase 3 5, Phase 2 7, Phase 1/2 1) 2000: 16 trials (Not applicable 2, Phase 3 4, Phase 2 10) 2001: 17 trials (Observational 3, Phase 3 5, Phase 2/3 1, Phase 2 6, Phase 1/2 2) 2002: 15 trials (Observational 2, Phase 4 1, Phase 3 6, Phase 2/3 1, Phase 2 5) 2003: 11 trials (Not applicable 1, Phase 3 7, Phase 2 2, Phase 1/2 1) 2004: 20 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 8, Phase 2/3 1, Phase 2 7, Phase 1/2 1) 2005: 19 trials (Observational 4, Not applicable 1, Phase 3 8, Phase 2/3 1, Phase 2 4, Phase 1/2 1) 2006: 31 trials (Observational 5, Not applicable 3, Phase 3 14, Phase 2/3 1, Phase 2 6, Phase 1/2 1, Phase 1 1) 2007: 32 trials (Observational 7, Not applicable 5, Phase 4 3, Phase 3 9, Phase 2 5, Phase 1/2 1, Phase 1 2) 2008: 25 trials (Observational 3, Not applicable 2, Phase 4 2, Phase 3 10, Phase 2/3 1, Phase 2 3, Phase 1 4) 2009: 40 trials (Observational 5, Not applicable 1, Phase 4 1, Phase 3 19, Phase 2 12, Phase 1 2) 2010: 39 trials (Observational 6, Not applicable 5, Phase 3 14, Phase 2/3 1, Phase 2 11, Phase 1/2 2) 2011: 40 trials (Observational 9, Not applicable 3, Phase 3 13, Phase 2 11, Phase 1/2 2, Phase 1 2) 2012: 39 trials (Observational 3, Not applicable 3, Phase 4 2, Phase 3 14, Phase 2 12, Phase 1/2 3, Phase 1 2) 2013: 32 trials (Observational 3, Not applicable 4, Phase 4 2, Phase 3 6, Phase 2/3 4, Phase 2 13) 2014: 59 trials (Observational 4, Not applicable 10, Phase 4 1, Phase 3 15, Phase 2/3 8, Phase 2 11, Phase 1/2 7, Phase 1 3) 2015: 76 trials (Observational 10, Not applicable 9, Phase 4 4, Phase 3 16, Phase 2/3 3, Phase 2 23, Phase 1/2 5, Phase 1 6) 2016: 50 trials (Observational 7, Not applicable 9, Phase 4 1, Phase 3 15, Phase 2/3 2, Phase 2 9, Phase 1/2 2, Phase 1 5) 2017: 78 trials (Observational 4, Not applicable 11, Phase 4 2, Phase 3 22, Phase 2/3 3, Phase 2 25, Phase 1/2 5, Phase 1 6) 2018: 70 trials (Observational 10, Not applicable 19, Phase 4 1, Phase 3 13, Phase 2/3 2, Phase 2 15, Phase 1/2 5, Phase 1 5) 2019: 89 trials (Observational 13, Not applicable 23, Phase 4 2, Phase 3 14, Phase 2/3 4, Phase 2 20, Phase 1/2 6, Phase 1 7) 2020: 76 trials (Observational 11, Not applicable 12, Phase 4 2, Phase 3 15, Phase 2/3 3, Phase 2 17, Phase 1/2 7, Phase 1 9) 2021: 88 trials (Observational 10, Not applicable 14, Phase 4 3, Phase 3 28, Phase 2/3 2, Phase 2 14, Phase 1/2 6, Phase 1 11) 2022: 66 trials (Observational 7, Not applicable 8, Phase 4 5, Phase 3 15, Phase 2/3 7, Phase 2 16, Phase 1/2 3, Phase 1 5) 2023: 78 trials (Observational 11, Not applicable 13, Phase 4 2, Phase 3 15, Phase 2/3 2, Phase 2 18, Phase 1/2 5, Phase 1 12) 2024: 66 trials (Observational 7, Not applicable 15, Phase 4 4, Phase 3 14, Phase 2/3 2, Phase 2 13, Phase 1/2 4, Phase 1 7) 2025: 73 trials (Observational 6, Not applicable 13, Phase 4 2, Phase 3 27, Phase 2/3 3, Phase 2 15, Phase 1/2 1, Phase 1 6)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 41
2025 73
2024 66
2023 78
2022 66
2021 88
2020 76
2019 89
2018 70
2017 78

2026 is partial: trials registered with a 2026 start date so far, not a full year. 4 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.